Search
forResearch 5 of 69
- Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review
- 76708 Risk of Developing Scarring and Non-Scarring Alopecia with GLP-1 and GLP-1/GIP Agonist Utilization
- Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends
- The Clinical Center’s Blood Glucose Management Service
- A Systematic Review of the Cutaneous Adverse Effects of GLP-1 Agonists
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →